-The Indian Express Incomparable data sets, cherry-picking, and dubious statistical analysis are behind the claims of robust employment growth. Only 1.4 million jobs were added in 2017. Surjit Bhalla has invented an estimate that 15 million jobs were created in 2017 (‘Robust job growth, not fake news,’ IE, April 28). This is an Invention; it is not a discovery or an inference by honest statistical analysis. It is an Invention because Bhalla...
More »SEARCH RESULT
Total Matching Records found : 89
Member of PM's Advisory Council Accused of 'Inventing' Employment Data
-TheWire.in Surjit Bhalla, who draws on CMIE’s database and EPFO data, notes that job creation in 2017 was likely 15 million. New Delhi: The head of the Centre for Monitoring of Indian Economy (CMIE) has accused economist Surjit Bhalla, who is a member of the Prime Minister’s Economic Advisory Council (PMEAC), of distorting and “dishonestly presenting” its nationwide employment survey to claim that India created 15 million jobs in 2017. The CMIE does...
More »India shocks with vaccine patent -Latha Jishnu
-Down to Earth Why did we grant Pfizer's claim on a pneumonia vaccine which has been rejected elsewhere? In august, the medical and public health fraternity was stunned when India’s Patent Office granted US pharma giant Pfizer’s claim on its vaccine against pneumonia, the pneumococcal conjugate vaccine (PCV), marketed as Prevnar13. For a country that has stricter patentability criteria than most others, India’s decision was baffling because Pfizer’s patent has been rejected...
More »US places India yet again on IPR 'priority watch' list -Amiti Sen
-The Hindu Business Line Frowns on India’s IP laws; New Delhi unfazed, says laws are TRIPS-compliant New Delhi: Expressing its disappointment with India for not making adequate changes in its IP laws and regulations despite announcing its National IPR policy last year, the US Trade Representative’s (USTR) office has once again placed the country in the ‘priority watch’ list in this year’s edition of the Special 301 report. “Almost a year after the...
More »The battle over Bt cotton -Shamnad Basheer
-The Hindu While Monsanto and Indian seed companies spar, more worrying is the confused lawmaking underpinning regulation of patents Genetically Modified Organisms (GMOs) breed controversy like no other. Little wonder then that Monsanto’s much-maligned Bt cotton has spawned the mother of all intellectual property (IP) disputes in India, involving at least 15 different proceedings in various courts, government agencies and tribunals at last count. Most proceedings appear to have come at the behest...
More »
